Vitamin K deficiency bleeding and early infant male circumcision in Africa.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23884276.
- Also identified by DOI 10.1097/AOG.0b013e31828b2f5c and PMC identifier 3773869.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Early infant (1-60 days of life) male circumcision is being trialed in Africa as a human immunodeficiency virus prevention strategy. Postcircumcision bleeding is particularly concerning where most infants are breastfed, and thus these infants are at increased risk of vitamin K deficiency bleeding. During a circumcision trial, one infant bled for 90 minutes postprocedure. After discovering he had not received standard prophylactic vitamin K, we gave 2 mg phytomenadione (vitamin K1) intramuscularly; bleeding stopped within 30 minutes. Vitamin K's extremely rapid action is not commonly appreciated. Neonatal vitamin K has been shown to be cost-effective. To increase availability and promote awareness of its importance, especially in low-resource settings where blood products and transfusions are limited, vitamin K should be included in the World Health Organization's Model List of Essential Medicines for Children.
Medical subject headings
- Circumcision, Male
- Hemorrhage
- Vitamin K 1
- Vitamin K Deficiency
- Vitamins